Stada rises on market talk of bid by Teva

FRANKFURT (Reuters) – Shares in German generic drugmaker Stada Arzneimittel rose as much as 4 percent as traders pointed to market talk that larger rival Teva could make an offer at 42 euros ($56.78)…


Leave a Reply

Your email address will not be published.